Copyright © 1995 by the European Society of Cardiology.
© 1995 The European Society of Cardiology
Heart rate variability and functional severity of congestive heart failure secondary to coronary artery disease
Cardiology Unit, Ospedale San Giovanni di Dio
*Department of Electronic Engineering Florence, Italy
accepted 11 August 1994.
Correspondence. Gian Carlo Casolo, MD, PhD, Via A Canova, 212, 50142 Florence, Italy
Abstract
To investigate the behaviour of heart rate variability (HRV) with the advancing severity of heart failure (CHF) we studied 20 normal subjects and 80 coronary artery disease (CAD) patients in sinus rhythm. CAD patients were selected consecutively in order to form four equal groups of 20 subjects with different degrees of CHF according to the New York Heart Association (NYHA) functional classification. In each subject a 24 h ECG Holier tape was recorded and subsequently analysed to obtain measures of heart rate and HRV. We used several measures of HR and both spectral and non-spectral measures of HRV. Among these we employed the width of the R-R interval distribution over 24 h at three different heights (TV, 10%Var, 50%Var).
The CAD group showed significantly lower HRV counts and smaller spectral components tlxan controls. However, these differences were due to the presence of CHF rather than to CAD. Indeed, a progressive and significant increase in heart rate and a contemporary decrease in HRV was observed with the advancing severity of CHF. Class IV patients had the smallest HR variation; the spectral composition in this group was barely detectable. The decrease in time domain measures of HRV followed the increase in NYHA Class in a progressive and regular pattern, while the low frequency and high frequency spectral power showed the largest reduction from NYHA Class I to NYHA Class II patients. No significant diange was demonstrated in NYHA Class I patients as compared to Controls.
A significant direct correlation was found between left ventricular ejection fraction (EF) and all the measures of HRV examined (EF vs SDNN, r=0.77, P<0.0001). However, this relationship was not evident when both Controls and the single CHF Classes were considered separately. Both EF and the clinical status significantly and independently affected HRV (multiple regression analysis; NYHA Class vs EF, P<0.002 and vs 10%Var, P<0.0001).
These data show that the extent of HRV reduction in CAD is related to the severity of the functional impairment and it is significantly affected by the degree of left ventricular dysfunction.
Key Words: Heart rate variability • congestive heart failure • autonomic nervous system • ambulatory ECG monitoring
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Shibata, R. Zhang, J. Hastings, Q. Fu, K. Okazaki, K.-i. Iwasaki, and B. D. Levine Cascade model of ventricular-arterial coupling and arterial-cardiac baroreflex function for cardiovascular variability in humans Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2142 - H2151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G A Lanza, D Cianflone, A G Rebuzzi, G Angeloni, A Sestito, G Ciriello, G La Torre, F Crea, A Maseri, and for the Stratificazione Prognostica dell'Angina In Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina Heart, August 1, 2006; 92(8): 1055 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tulppo and H. V. Huikuri Origin and significance of heart rate variability J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2278 - 2280. [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Murray What Is "Heart Rate Variability" and Is It Blunted by Tumor Necrosis Factor? Chest, March 1, 2003; 123(3): 664 - 667. [Full Text] [PDF]
|
|
|
|
|
|
H. A. Malave, A. A. Taylor, J. Nattama, A. Deswal, and D. L. Mann Circulating Levels of Tumor Necrosis Factor Correlate With Indexes of Depressed Heart Rate Variability: A Study in Patients With Mild-to-Moderate Heart Failure Chest, March 1, 2003; 123(3): 716 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Malpas Neural influences on cardiovascular variability: possibilities and pitfalls Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H6 - H20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. El-Omar, A. Kardos, and B. Casadei Mechanisms of respiratory sinus arrhythmia in patients with mild heart failure Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H125 - H131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kikuya, A. Hozawa, T. Ohokubo, I. Tsuji, M. Michimata, M. Matsubara, M. Ota, K. Nagai, T. Araki, H. Satoh, et al. Prognostic Significance of Blood Pressure and Heart Rate Variabilities : The Ohasama Study Hypertension, November 1, 2000; 36(5): 901 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Leong, P. Mann, M. Wallymahmed, I. A. MacFarlane, and J. P. H. Wilding Abnormal Heart Rate Variability in Adults with Growth Hormone Deficiency J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 628 - 633. [Abstract] [Full Text]
|
|
|
|
 |
|
 J Gunn and D Cumberland Stent coatings and local drug delivery. State of the art Eur. Heart J., December 1, 1999; 20(23): 1693 - 1700. [PDF]
|
|